Public health impact Target buyers include healthcare providers and public health organizations seeking non-narcotic OTC pain relief options to combat prescription opioid misuse; position LEVARE as a safer alternative for pain management programs and community health initiatives.

Early market entry Leverage LEVARE’s recent launch momentum to pursue regional distributors, pharmacies, and healthcare retailers eager to expand non-narcotic pain relief lines and capitalize on growing opioid misuse awareness.

Regulatory positioning Highlight U.S. market focus and clinically tested, non-narcotic profile to approach formulary committees and OTC product listings, aiming to secure shelf space in pharmacies and wellness retailers.

Strategic partnerships Identify collaboration opportunities with contract manufacturers, private-label manufacturers, and wellness brands to expand product reach, accelerate scale, and reduce go-to-market timelines.

Growth benchmarks With current revenue in the low millions and a lean team, target channel expansion through e-commerce, healthcare distributors, and anchor retailers to build brand awareness and drive first-time and repeat purchases.